Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy

Nature Medicine
A LarochelleJ E Dick

Abstract

The development of stem-cell gene therapy is hindered by the absence of repopulation assays for primitive human hematopoietic cells. Current methods of gene transfer rely on in vitro colony-forming cell (CFC) and long-term culture-initiating cell (LTC-IC) assays, as well as inference from other mammalian species. We have identified a novel human hematopoietic cell, the SCID-repopulating cell (SRC), a cell more primitive than most LTC-ICs and CFCs. The SRC, exclusively present in the CD4+CD8- fraction, is capable of multilineage repopulation of the bone marrow of nonobese diabetic mice with severe combined immunodeficiency disease (NOD/SCID mice). SRCs were rarely transduced with retroviruses, distinguishing them from most CFCs and LTC-ICs. This observation is consistent with the low level of gene marking seen in human gene therapy trials. An SRC assay may aid in the characterization of hematopoiesis, as well as the improvement of transduction methods.

References

Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C M BaumB Peault
May 8, 1992·Science·W F Anderson
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B LimD A Williams
May 1, 1993·The Journal of Experimental Medicine·W CraigP M Lansdorp
Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·J A NoltaD B Kohn
Aug 1, 1996·Seminars in Immunology·J E Dick

❮ Previous
Next ❯

Citations

Mar 20, 2001·Biotechnology and Bioengineering·A W Greenberg, D A Hammer
Apr 5, 2002·The Journal of Gene Medicine·Thomas RelanderJohan Richter
May 25, 2001·International Journal of Hematology·T Nakahata
May 25, 2001·International Journal of Hematology·J Richter, S Karlsson
Jun 4, 2002·International Journal of Hematology·Tatsutoshi Nakahata, Hano Toru
Aug 16, 2001·International Journal of Hematology·Takahiro UedaKohichiro Tsuji
Dec 2, 2006·Veterinary Research Communications·S E SuterP S Henthorn
Dec 11, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·José María García BuenoCarmen Ramírez-Castillejo
Jan 22, 2004·Archives of Medical Research·Stephen J Szilvassy
Jan 22, 2004·Archives of Medical Research·Juan A BuerenJosé C Segovia
Jan 22, 2004·Archives of Medical Research·Albertus W WognumTerry E Thomas
May 30, 2001·Experimental Hematology·G P NiemeyerC D Lothrop
Mar 20, 2003·Experimental Hematology·Loretta GammaitoniWanda Piacibello
Mar 12, 2004·Cancer Letters·Ariel Ruiz i AltabaPilar Sánchez
Jan 27, 1998·Hematology/oncology Clinics of North America·O P VeibyH R Snodgrass
Aug 10, 1999·Critical Reviews in Oncology/hematology·C LutzkoA K Stewart
Aug 1, 1997·Molecular Medicine Today·R MazeD A Williams
Nov 13, 2008·Cytotechnology·Andrew D ClarkTessa L Holyoake
Oct 9, 2002·Immunological Reviews·Andris AvotsAlbrecht M Müller
Mar 20, 2012·Cellular & Molecular Immunology·Adam C DrakeJianzhu Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.